What is Combi-Blocks?
Combi-Blocks operates as a research-driven manufacturer and global supplier of laboratory reagents. The company's specialization encompasses a broad spectrum of chemical compounds, including essential building blocks like boronic acids, imidazoles, and amino acids. These products are critical for researchers and laboratories worldwide, supporting diverse scientific applications. Combi-Blocks enhances accessibility through multiple sales channels, notably its online shopping system, serving a wide-ranging clientele across major global markets including Brazil, China, Europe, India, Japan, and Korea.
How much funding has Combi-Blocks raised?
Combi-Blocks has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Combi-Blocks
PPP
Public-Private Partnership
What's next for Combi-Blocks?
The substantial backing Combi-Blocks has received, particularly the recent strategic investment, signals a phase of accelerated growth and potential market consolidation. This capital infusion is likely to fuel further research and development into novel chemical compounds, expand manufacturing capabilities, and strengthen its global distribution network. The company's focus on providing foundational reagents positions it to capitalize on advancements across various scientific disciplines, from pharmaceuticals to materials science.
See full Combi-Blocks company page
